Skip to main content

Advertisement

SpringerLink
Log in

Coronary Vessel Wall Imaging: State of the Art and Future Directions

  • Cardiac Magnetic Resonance (V Püntmann and E Nagel, Section Editors)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The purpose of this paper is to review the latest advancements and developments in non-invasive coronary magnetic resonance (MR) and hybrid positron emission tomography (PET)/MR imaging.

Recent Findings

Coronary MRI has advanced in recent years in different aspects, especially regarding technical developments, scan protocols, and molecular probes. Recently introduced hybrid PET/MR scanners have already demonstrated great potential in improving cardiovascular imaging.

Summary

Coronary atherosclerosis and acute myocardial infarction remain major threats to physical health worldwide. Several techniques, from invasive intravascular imaging to non-invasive imaging methods, are studied extensively to identify patients with vulnerable plaques at risk for adverse coronary events. While imaging of vulnerable plaques is getting more and more sophisticated, the clinical impact of molecular plaque imaging on prognosis and disease management still has to be fully defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–25. https://doi.org/10.1038/nature10146.

    Article  CAS  PubMed  Google Scholar 

  2. Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G, et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 2017;281(5):471–82. https://doi.org/10.1111/joim.12605.

    Article  CAS  PubMed  Google Scholar 

  3. Schunkert H. Genetics of CVD in 2017: expanding the spectrum of CVD genetics. Nat Rev Cardiol. 2018;15(2):77–8. https://doi.org/10.1038/nrcardio.2017.209.

    Article  PubMed  Google Scholar 

  4. Verweij N, Eppinga RN, Hagemeijer Y, van der Harst P. Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure. Sci Rep. 2017;7(1):2761. https://doi.org/10.1038/s41598-017-03062-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459–72. https://doi.org/10.1093/eurheartj/ehx144.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol. 2018;72(10):1141–56. https://doi.org/10.1016/j.jacc.2018.06.046.

    Article  CAS  PubMed  Google Scholar 

  7. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67. https://doi.org/10.1016/S0140-6736(15)01225-8.

    Article  PubMed  Google Scholar 

  8. Libby P, Ridker PM, Hansson GK. Leducq transatlantic network on a. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–38. https://doi.org/10.1016/j.jacc.2009.09.009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Libby P. Interleukin-1 Beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017;70(18):2278–89. https://doi.org/10.1016/j.jacc.2017.09.028.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–66. https://doi.org/10.1161/CIRCRESAHA.114.302721.

    Article  CAS  PubMed  Google Scholar 

  11. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and National Burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. https://doi.org/10.1016/j.jacc.2017.04.052.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–32. https://doi.org/10.1056/NEJMoa1710261.

    Article  PubMed  Google Scholar 

  13. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343(13):915–22. https://doi.org/10.1056/NEJM200009283431303.

    Article  CAS  PubMed  Google Scholar 

  14. Sugiyama T, Yamamoto E, Bryniarski K, Xing L, Lee H, Isobe M, et al. Nonculprit plaque characteristics in patients with acute coronary syndrome caused by plaque Erosion vs plaque rupture: a 3-vessel optical coherence tomography study. JAMA Cardiol. 2018;3(3):207–14. https://doi.org/10.1001/jamacardio.2017.5234.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation. 2001;103(22):2705–10.

    Article  CAS  PubMed  Google Scholar 

  16. Andrews JPM, Fayad ZA, Dweck MR. New methods to image unstable atherosclerotic plaques. Atherosclerosis. 2018;272:118–28. https://doi.org/10.1016/j.atherosclerosis.2018.03.021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103(7):934–40.

    Article  CAS  PubMed  Google Scholar 

  18. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart. 1999;82(3):265–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sato Y, Hatakeyama K, Marutsuka K, Asada Y. Incidence of asymptomatic coronary thrombosis and plaque disruption: comparison of non-cardiac and cardiac deaths among autopsy cases. Thromb Res. 2009;124(1):19–23. https://doi.org/10.1016/j.thromres.2008.08.026.

    Article  CAS  PubMed  Google Scholar 

  20. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(8 Suppl):C13–8. https://doi.org/10.1016/j.jacc.2005.10.065.

    Article  CAS  PubMed  Google Scholar 

  21. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–95. https://doi.org/10.1056/NEJMoa0907272.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004–13. https://doi.org/10.1056/NEJMra1216063.

    Article  CAS  PubMed  Google Scholar 

  23. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–22. https://doi.org/10.1056/NEJMoa1615664.

    Article  CAS  PubMed  Google Scholar 

  24. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–31. https://doi.org/10.1056/NEJMoa1707914.

    Article  CAS  PubMed  Google Scholar 

  25. Jansen CHP, Perera D, Wiethoff AJ, Phinikaridou A, Razavi RM, Rinaldi A, et al. Contrast-enhanced magnetic resonance imaging for the detection of ruptured coronary plaques in patients with acute myocardial infarction. PLoS One. 2017;12(11):e0188292. https://doi.org/10.1371/journal.pone.0188292.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058–72. https://doi.org/10.1016/j.jacc.2011.09.079.

    Article  PubMed  Google Scholar 

  27. Bourantas CV, Jaffer FA, Gijsen FJ, van Soest G, Madden SP, Courtney BK, et al. Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology. Eur Heart J. 2017;38(6):400–12. https://doi.org/10.1093/eurheartj/ehw097.

    Article  PubMed  Google Scholar 

  28. Investigators S-H, Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379(10):924–33. https://doi.org/10.1056/NEJMoa1805971.

    Article  Google Scholar 

  29. Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol. 2018;3(2):144–52. https://doi.org/10.1001/jamacardio.2017.4973.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Makowski MR, Henningsson M, Spuentrup E, Kim WY, Maintz D, Manning WJ, et al. Characterization of coronary atherosclerosis by magnetic resonance imaging. Circulation. 2013;128(11):1244–55. https://doi.org/10.1161/CIRCULATIONAHA.113.002681.

    Article  PubMed  Google Scholar 

  31. Robson PM, Dey D, Newby DE, Berman D, Li D, Fayad ZA, et al. MR/PET Imaging of the Cardiovascular System. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1165–79. https://doi.org/10.1016/j.jcmg.2017.07.008.

    Article  PubMed  PubMed Central  Google Scholar 

  32. •• Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, et al. Coronary artery PET/MR imaging: feasibility, limitations, and solutions. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1103–12. https://doi.org/10.1016/j.jcmg.2016.09.029 First successful coronary PET/MR imaging of microcalcification and inflammation.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95. https://doi.org/10.1056/NEJMra043430.

    Article  CAS  PubMed  Google Scholar 

  34. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007;116(16):1832–44. https://doi.org/10.1161/CIRCULATIONAHA.106.676890.

    Article  CAS  PubMed  Google Scholar 

  35. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354(12):1264–72. https://doi.org/10.1056/NEJMoa054013.

    Article  CAS  PubMed  Google Scholar 

  36. Kathiresan S. Myocardial infarction genetics C. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. N Engl J Med. 2008;358(21):2299–300. https://doi.org/10.1056/NEJMc0707445.

    Article  CAS  PubMed  Google Scholar 

  37. Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, Virmani R. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol. 2007;49(21):2093–101. https://doi.org/10.1016/j.jacc.2006.10.083.

    Article  CAS  PubMed  Google Scholar 

  38. Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, et al. Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res. 2005;28(10):837–45. https://doi.org/10.1291/hypres.28.837.

    Article  CAS  PubMed  Google Scholar 

  39. Sluimer JC, Kolodgie FD, Bijnens AP, Maxfield K, Pacheco E, Kutys B, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol. 2009;53(17):1517–27. https://doi.org/10.1016/j.jacc.2008.12.056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25(10):2054–61. https://doi.org/10.1161/01.ATV.0000178991.71605.18.

    Article  CAS  PubMed  Google Scholar 

  41. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349(24):2316–25. https://doi.org/10.1056/NEJMoa035655.

    Article  CAS  PubMed  Google Scholar 

  42. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;116(24):2841–50. https://doi.org/10.1161/CIRCULATIONAHA.107.732867.

    Article  CAS  PubMed  Google Scholar 

  43. Joshi NV, Vesey A, Newby DE, Dweck MR. Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques? Curr Cardiol Rep. 2014;16(9):521. https://doi.org/10.1007/s11886-014-0521-4.

    Article  PubMed  Google Scholar 

  44. Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun. 2015;6:7495. https://doi.org/10.1038/ncomms8495.

    Article  PubMed  Google Scholar 

  45. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22):1371–5. https://doi.org/10.1056/NEJM198705283162204.

    Article  CAS  PubMed  Google Scholar 

  46. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262–75.

    Article  CAS  PubMed  Google Scholar 

  47. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002;15(6):439–46.

    Article  PubMed  Google Scholar 

  48. Cheng JM, Garcia-Garcia HM, de Boer SP, Kardys I, Heo JH, Akkerhuis KM, et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J. 2014;35(10):639–47. https://doi.org/10.1093/eurheartj/eht484.

    Article  PubMed  Google Scholar 

  49. Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013;61(10):1041–51. https://doi.org/10.1016/j.jacc.2012.10.054.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 2014;114(12):1867–79. https://doi.org/10.1161/CIRCRESAHA.114.302699.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Mittleman MA, Mostofsky E. Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation. 2011;124(3):346–54. https://doi.org/10.1161/CIRCULATIONAHA.110.968776.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010;10(2):83–92. https://doi.org/10.1016/S1473-3099(09)70331-7.

    Article  PubMed  Google Scholar 

  53. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345–53. https://doi.org/10.1056/NEJMoa1702090.

    Article  PubMed  Google Scholar 

  54. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345(26):1863–9. https://doi.org/10.1056/NEJMoa010866.

    Article  CAS  PubMed  Google Scholar 

  55. Maintz D, Ozgun M, Hoffmeier A, Fischbach R, Kim WY, Stuber M, et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J. 2006;27(14):1732–6. https://doi.org/10.1093/eurheartj/ehl102.

    Article  PubMed  Google Scholar 

  56. Kawasaki T, Koga S, Koga N, Noguchi T, Tanaka H, Koga H, et al. Characterization of hyperintense plaque with noncontrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound. JACC Cardiovasc Imaging. 2009;2(6):720–8. https://doi.org/10.1016/j.jcmg.2009.01.016.

    Article  PubMed  Google Scholar 

  57. Jansen CH, Perera D, Makowski MR, Wiethoff AJ, Phinikaridou A, Razavi RM, et al. Detection of intracoronary thrombus by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 2011;124(4):416–24. https://doi.org/10.1161/CIRCULATIONAHA.110.965442.

    Article  CAS  PubMed  Google Scholar 

  58. Xie Y, Kim YJ, Pang J, Kim JS, Yang Q, Wei J, et al. Coronary atherosclerosis T1-weighed characterization with integrated anatomical reference: comparison with high-risk plaque features detected by invasive coronary imaging. JACC Cardiovasc Imaging. 2017;10(6):637–48. https://doi.org/10.1016/j.jcmg.2016.06.014.

    Article  PubMed  Google Scholar 

  59. Matsumoto K, Ehara S, Hasegawa T, Sakaguchi M, Otsuka K, Yoshikawa J, et al. Localization of coronary high-intensity signals on T1-weighted MR imaging: relation to plaque morphology and clinical severity of angina pectoris. JACC Cardiovasc Imaging. 2015;8(10):1143–52. https://doi.org/10.1016/j.jcmg.2015.06.013.

    Article  PubMed  Google Scholar 

  60. • Noguchi T, Kawasaki T, Tanaka A, Yasuda S, Goto Y, Ishihara M, et al. High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. J Am Coll Cardiol. 2014;63(10):989–99. https://doi.org/10.1016/j.jacc.2013.11.034 This study demonstrated an association between high intensity plaques and adverse coronary events.

    Article  PubMed  Google Scholar 

  61. He Y, Da QY, An J, Song XT, Li DB. Coronary artery plaque imaging: comparison of black-blood MRI and 64-multidetector computed tomography. Chronic Dis Transl Med. 2016;2(3):159–65. https://doi.org/10.1016/j.cdtm.2016.11.007.

    Article  PubMed  PubMed Central  Google Scholar 

  62. von Zur MC, Reiss S, Krafft AJ, Besch L, Menza M, Zehender M, et al. Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency. PLoS One. 2018;13(1):e0191413. https://doi.org/10.1371/journal.pone.0191413.

    Article  CAS  Google Scholar 

  63. Millon A, Boussel L, Brevet M, Mathevet JL, Canet-Soulas E, Mory C, et al. Clinical and histological significance of gadolinium enhancement in carotid atherosclerotic plaque. Stroke. 2012;43(11):3023–8. https://doi.org/10.1161/STROKEAHA.112.662692.

    Article  PubMed  Google Scholar 

  64. Schneeweis C, Schnackenburg B, Stuber M, Berger A, Schneider U, Yu J, et al. Delayed contrast-enhanced MRI of the coronary artery wall in takayasu arteritis. PLoS One. 2012;7(12):e50655. https://doi.org/10.1371/journal.pone.0050655.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Varma N, Hinojar R, D'Cruz D, Arroyo Ucar E, Indermuehle A, Peel S, et al. Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients. JACC Cardiovasc Imaging. 2014;7(8):762–70. https://doi.org/10.1016/j.jcmg.2014.03.012.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Ibrahim T, Makowski MR, Jankauskas A, Maintz D, Karch M, Schachoff S, et al. Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imaging. 2009;2(5):580–8. https://doi.org/10.1016/j.jcmg.2008.12.029.

    Article  PubMed  Google Scholar 

  67. Mora S, Yanek LR, Moy TF, Fallin MD, Becker LC, Becker DM. Interaction of body mass index and Framingham risk score in predicting incident coronary disease in families. Circulation. 2005;111(15):1871–6. https://doi.org/10.1161/01.CIR.0000161956.75255.7B.

    Article  PubMed  Google Scholar 

  68. Makowski MR, Jansen CHP, Ebersberger U, Schaeffter T, Razavi R, Mangino M, et al. Influence of acquired obesity on coronary vessel wall late gadolinium enhancement in discordant monozygote twins. Eur Radiol. 2017;27(11):4612–8. https://doi.org/10.1007/s00330-016-4616-8.

    Article  PubMed  Google Scholar 

  69. Engel LC, Landmesser U, Gigengack K, Wurster T, Manes C, Girke G, et al. Novel approach for in vivo detection of vulnerable coronary plaques using molecular 3-T CMR imaging with an albumin-binding probe. JACC Cardiovasc Imaging. 2018;12:297–306. https://doi.org/10.1016/j.jcmg.2017.10.026.

    Article  PubMed  Google Scholar 

  70. Dweck MR, Williams MC, Moss AJ, Newby DE, Fayad ZA. Computed tomography and cardiac magnetic resonance in ischemic heart disease. J Am Coll Cardiol. 2016;68(20):2201–16. https://doi.org/10.1016/j.jacc.2016.08.047.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, Manning WJ. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation. 2000;102(21):2582–7.

    Article  CAS  PubMed  Google Scholar 

  72. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102(5):506–10.

    Article  CAS  PubMed  Google Scholar 

  73. Sakuma H. Coronary CT versus MR angiography: the role of MR angiography. Radiology. 2011;258(2):340–9. https://doi.org/10.1148/radiol.10100116.

    Article  PubMed  Google Scholar 

  74. Yang Q, Li K, Liu X, Du X, Bi X, Huang F, et al. 3.0T whole-heart coronary magnetic resonance angiography performed with 32-channel cardiac coils: a single-center experience. Circ Cardiovasc Imaging. 2012;5(5):573–9. https://doi.org/10.1161/CIRCIMAGING.112.974972.

    Article  PubMed  Google Scholar 

  75. Celeng C, de Keizer B, Merkely B, de Jong P, Leiner T, Takx RAP. PET molecular targets and near-infrared fluorescence imaging of atherosclerosis. Curr Cardiol Rep. 2018;20(2):11. https://doi.org/10.1007/s11886-018-0953-3.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383(9918):705–13. https://doi.org/10.1016/S0140-6736(13)61754-7.

    Article  PubMed  Google Scholar 

  77. Puntmann VO, Valbuena S, Hinojar R, Petersen SE, Greenwood JP, Kramer CM, et al. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I—analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018;20(1):67. https://doi.org/10.1186/s12968-018-0484-5.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Sakaguchi M, Hasegawa T, Ehara S, Matsumoto K, Mizutani K, Iguchi T, et al. New insights into spotty calcification and plaque rupture in acute coronary syndrome: an optical coherence tomography study. Heart Vessel. 2016;31(12):1915–22. https://doi.org/10.1007/s00380-016-0820-3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany

    Thomas Wurster, Ulf Landmesser, Leif-Christopher Engel & Boris Bigalke

  2. Berlin Institute of Health, Berlin, Germany

    Thomas Wurster, Ulf Landmesser & Leif-Christopher Engel

  3. DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany

    Ulf Landmesser

  4. Klinik für Radiologie, Charité Campus Mitte, Universitätsmedizin Berlin, Berlin, Germany

    Marcus Makowski

Authors
  1. Thomas Wurster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulf Landmesser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leif-Christopher Engel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Boris Bigalke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marcus Makowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Wurster.

Ethics declarations

Conflict of Interest

Thomas Heinrich Wurster is a participant in the Berlin Institute of Health Charité Clinician Scientist Program funded by Charité-Universitätsmedizin Berlin and Berlin Institute of Health.

Ulf Landmesser has nothing to disclose.

Leif-Christopher Engel has nothing to disclose.

Marcus Makowski has nothing to disclose.

Boris Bigalke is employed by Charité Universitätsmedizin Berlin.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Topical Collection on Cardiac Magnetic Resonance

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wurster, T., Landmesser, U., Engel, LC. et al. Coronary Vessel Wall Imaging: State of the Art and Future Directions. Curr Cardiovasc Imaging Rep 12, 16 (2019). https://doi.org/10.1007/s12410-019-9493-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12410-019-9493-5

Keywords

Search

Navigation